The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
Vicker N, Sharland CM, Heaton WB, Gonzalez AM, Bailey HV, Smith A, Springall JS, Day JM, Tutill HJ, Reed MJ, Purohit A, Potter BV.
Vicker N, et al. Among authors: reed mj.
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):259-65. doi: 10.1016/j.mce.2008.08.005. Epub 2008 Aug 15.
Mol Cell Endocrinol. 2009.
PMID: 18775469